Latest Regulatory News

Challenger Limited has welcomed APRA’s new capital framework for longevity products, set to ease capital requirements and reduce risk for providers, supporting Australia’s evolving retirement income market.

Kairos Minerals has secured shareholder approval to rebrand as Pilbara Gold Limited and consolidate its shares on a 1-for-15 basis, signalling a new chapter for the company’s gold exploration ambitions.

ARN Media is confronting a substantial legal claim from former contractor Jacqueline Henderson, who alleges adverse action and bullying following her contract termination. The case also challenges previous ASX disclosures, with compensation sought exceeding $82 million.

The U.S. District Court has upheld the federal permit for Ioneer’s Rhyolite Ridge project, removing key legal obstacles and enabling the company to advance construction of its critical minerals mine in Nevada.

ClearVue Technologies has achieved a key international certification for its innovative solar panels and is deepening its strategic alliance with Helios Power, setting the stage for expanded commercial deployment in the building-integrated photovoltaics market.

Optiscan Imaging Ltd has taken a significant step towards commercialising its InSpecta® veterinary imaging device in the US by submitting a regulatory dossier to the FDA. This milestone not only initiates formal review but also sets the stage for broader clinical adoption and future device approvals.

Firebrick Pharma has successfully secured $1.5 million through a strategic placement, positioning itself to accelerate business development and launch new products in key markets.

Jade Gas Holdings has raised A$1.8 million through a well-supported placement to fund the development of Mongolia’s inaugural commercial gas production from the Red Lake gas field. This capital injection positions the company to advance key milestones in its flagship coal bed methane project.

Hastings Technology Metals has acquired a 49% stake in a fully permitted rare earth processing plant in Thailand, aiming to commence production by late 2026. This strategic move offers a lower-cost, near-term production hub with potential to process feedstock from its Yangibana project.

Cleo Diagnostics has completed blood sample collection for its pivotal U.S. clinical trial, advancing its Pre-Surgical Ovarian Cancer Test closer to FDA submission.

AIC Mines reports significant growth in Mineral Resources and Ore Reserves at its Eloise Copper Mine and Jericho Copper Project, underpinning potential mine-life extensions and production growth.

Nexsen Limited's subsidiary has won a HK$6 million grant to accelerate clinical validation and manufacturing of its rapid Group B Streptococcus diagnostic in Hong Kong, positioning the city as a key Asia-Pacific hub.